艾灸治疗缓解期支气管哮喘疗效观察  

Observation on treating bronchial asthma in remission by moxibustion

作　　者：张春霞 Zhang Chunxia

机构地区：[1]新疆图木舒克市人民医院,新疆图木舒克843900

出　　处：《中医临床研究》2021年第25期60-62,共3页Clinical Journal Of Chinese Medicine

摘　　要：目的:探讨艾灸治疗缓解期支气管哮喘的疗效。方法:选取2018年1月-2019年12月新疆图木舒克市人民医院收治的缓解期支气管哮喘患者94例,随机将患者分为对照组(47例)与研究组(47例),对照组采取口服固肾定喘丸治疗,研究组在对照组基础上予艾灸治疗,连续治疗3个月,与本地其他医院联合检测免疫球蛋白E与肿瘤坏死因子α,比较两组患者治疗前后免疫球蛋白E、肿瘤坏死因子α,中医症状、哮喘控制情况与治疗效果。结果:治疗前两组患者免疫球蛋白E水平、中医症状、哮喘控制情况的差异无统计学意义(P>0.05),治疗后两组免疫球蛋白E水平均显著下降,且研究组水平显著更低(P<0.05);同时治疗后研究组各中医症状评分显著低于对照组,哮喘控制测试评分显著高于对照组(P<0.05)。研究组治疗总有效率显著高于对照组(P<0.05)。结论:缓解期支气管哮喘患者采取艾灸治疗效果显著,可有效提高患者免疫能力,改善各项临床症状,进而有效控制病情,具有较高的临床价值。Objective:To explore efficacy of moxibustion on bronchial asthma in remission.Methods:Ninety-four cases from January 2018 to December 2019 were divided into the control group(47 cases)and the study group(47 cases).The control group was treated with oral Gushen Dingchuan Wan(固肾定喘丸).The study group was treated by moxibustion on the basis of the control group for 3 consecutive months.Results:After treatment,the levels of immunoglobulin E in the two groups were decreased significantly,and the levels in the study group were significantly lower(P<0.05).The TCM symptom scores in the study group were significantly lower than the control group,and the asthma control test scores in the study group were significantly higher than the control group(P<0.05).The total efficiency in the study group was significantly higher than the control group(P<0.05).Conclusion:Moxibustion on bronchial asthma patients in remission period can effectively improve the immunity,ameliorate various clinical symptoms,and control the condition,which has high clinical value.

关 键 词：艾灸 支气管哮喘 缓解期 

分 类 号：R245.81[医药卫生—针灸推拿学]